Current clinical applications of endoscopic ultrasound

ANZ Journal of Surgery

Volumn 77, Issue 3, 2007, Pages 101-111

  Caddy, Grant R ^a   Chen, Robert Y ^a,b,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b Western Hospital   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Cancer staging; Endoscopic ultrasound; Fine needle aspiration; Review

Indexed keywords

ASPIRATION BIOPSY; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELIAC PLEXUS; CHRONIC PANCREATITIS; CLINICAL PRACTICE; COMMON BILE DUCT STONE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; ESOPHAGUS CANCER; GASTRECTOMY; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHADENOPATHY; NEUROLYSIS; PANCREAS CANCER; PANCREAS PSEUDOCYST; PATIENT CARE; PORTAL HYPERTENSION; RECTUM CANCER; REVIEW; STOMACH CANCER; STOMACH LYMPHOMA; SURGICAL DRAINAGE; SURVIVAL RATE; ULTRASOUND;

CARCINOMA, NON-SMALL-CELL LUNG; DIGESTIVE SYSTEM DISEASES; ENDOSONOGRAPHY; HUMANS; HYPERTENSION, PORTAL;

EID: 33846865084     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2006.03999.x     Document Type: Review

References (113)

1. Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut 2000; 46: 88-92.
2. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4.
3. Pfau PR, Ginsberg GG, Lew RJ, Brensinger CM, Kochman ML. EUS predictors of long-term survival in esophageal carcinoma. Gastrointest. Endosc. 2001; 53: 463-9.
4. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med. 1996; 335: 462-7.
5. Pfau PR, Chak A. Endoscopic ultrasonography. Endoscopy 2002; 34: 21-8.
6. Kelly S, Harris KM, Berry E et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49: 534-9.
7. Meining A, Dittler HJ, Wolf A et al. You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut 2002; 50: 599-603.
8. Wallace MB, Hoffman BJ, Sahai AS, Inoue H, Van Velse A, Hawes RH. Imaging of esophageal tumors with a water-filled condom and a catheter US probe. Gastrointest. Endosc. 2000; 51: 597-600.
9. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest. Endosc. 1997; 45: 474-9.
10. Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am. J. Gastroenterol. 2004; 99: 628-33.
11. Vazquez-Sequeiros E, Wiersema MJ, Clain JE et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125: 1626-35.
12. Romagnuolo J, Scott J, Hawes RH et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest. Endosc. 2002; 55: 648-54.
13. Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest. Endosc. 2001; 54: 689-96.
14. Buttar N, Wang K, Lutzke L, Krishnadath K. The use of endoscopic ultrasonography in Barrett's esophagus. Gastrointest. Endosc. 2001; 53: AB172.
15. Canto MIF, Cruz-Correa MR, Heitmiller RF, Kantsevoy RF, Kalloo AN. What is the accuracy of EUS lymph node staging in patients with Barrett's esophagus and high grade dysplasia or early cancer? A prospective study with implications for endoscopic therapy. Gastrointest. Endosc. 2001; 53: AB171.
16. Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy 1993; 25: 162-6.
17. Habermann CR, Weiss F, Riecken R et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CTand endoscopic US. Radiology 2004; 230: 465-71.
18. Willis S, Truong S, Gribnitz S, Fass J, Schumpelick V. Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy. Surg. Endosc. 2000; 14: 951-4.
19. Tio TL, Coene PP, Schouwink MH, Tytgat GN. Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology 1989; 173: 411-17.
20. Javaid G, Shah OJ, Dar MA, Shah P, Wani NA, Zargar SA. Role of endoscopic ultrasonography in preoperative staging of gastric carcinoma. ANZ J. Surg. 2004; 74: 108-11.
21. Perng DS, Jan CM, Wang WM et al. Computed tomography, endoscopic ultrasonography and intraoperative assessment in TN staging of gastric carcinoma. J. Formos. Med. Assoc. 1996; 95: 378-85.
22. Ziegler K, Sanft C, Zimmer T et al. Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut 1993; 34: 604-10.
23. Stolte M, Bayerdorffer E, Morgner A et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50: 19-24.
24. Sackmann M, Morgner A, Rudolph B et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997; 113: 1087-90.
25. Palazzo L, Roseau G, Ruskone-Fourmestraux A et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy 1993; 25: 502-8.
26. Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993; 113: 14-27.
27. Suekane H, Iida M, Yao T, Matsumoto T, Masuda Y, Fujishima M. Endoscopic ultrasonography in primary gastric lymphoma: correlation with endoscopic and histologic findings. Gastrointest. Endosc. 1993; 39: 139-45.
28. Levy M, Hammel P, Lamarque D et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest. Endosc. 1997; 46: 328-33.
29. Pavlick AC, Gerdes H, Portlock CS. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors. J. Clin. Oncol. 1997; 15: 1761-6.
30. Puspok A, Raderer M, Chott A, Dragosics B, Gangl A, Schofl R. Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma. Gut 2002; 51: 691-4.
31. Caletti G, Fusaroli P, Togliani T. EUS in MALT lymphoma. Gastrointest. Endosc. 2002; 56: S21-6.
32. Hunerbein M. Endorectal ultrasound in rectal cancer. Colorectal Dis. 2003; 5: 402-5.
33. Savides TJ, Master SS. EUS in rectal cancer. Gastrointest. Endosc. 2002; 56: S12-18.
34. Harewood GC, Wiersema MJ, Nelson H et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002; 123: 24-32.
35. Harewood GC. Assessment of clinical impact of endoscopic ultrasound on rectal cancer. Am. J. Gastroenterol. 2004; 99: 623-7.
36. Vanagunas A, Lin DE, Stryker SJ. Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am. J. Gastroenterol. 2004; 99: 109-12.
37. Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J. Clin. 2004; 54: 8-29.
38. Varadarajulu S, Wallace MB. Applications of endoscopic ultrasonography in pancreatic cancer. Cancer Control 2004; 11: 15-22.
39. Gress FG, Hawes RH, Savides TJ et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest. Endosc. 1999; 50: 786-91.
40. Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br. J. Surg. 1999; 86: 189-93.
41. Legmann P, Vignaux O, Dousset B et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am. J. Roentgenol. 1998; 170: 1315-22.
42. Tierney WM, Francis IR, Eckhauser F, Elta G, Nostrant TT, Scheiman JM. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest. Endosc. 2001; 53: 182-8.
43. Mertz HR, Sechopoulos P, Delbeke D, Leach SD EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest. Endosc. 2000; 52: 367-71.
44. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am. J. Gastroenterol. 2004; 99: 844-50.
45. Ahmad NA, Lewis JD, Siegelman ES, Rosato EF, Ginsberg GG, Kochman ML. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am. J. Gastroenterol. 2000; 95: 1926-31.
46. Lees WR. Endoscopic ultrasonography of chronic pancreatitis and pancreatic pseudocysts. Scand. J. Gastroenterol. 1986; 123: 123-9.
47. Wiersema MJ, Hawes RH, Lehman GA, Kochman ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993; 25: 555-64.
48. Sahai AV, Zimmerman M, Aabakken L et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest. Endosc. 1998; 48: 18-25.
49. Wallace MB, Hawes RH, Durkalski V et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest. Endosc. 2001; 53: 294-9.
50. Chen RY, Hino S, Aithal GP et al. Endoscopic ultrasound (EUS) features of chronic pancreatitis predate subsequent development of abnormal endoscopic retrograde pancreatogram (ERP). Gastrointest. Endosc. 2002; 55: AB242.
51. Canto MI, Chak A, Stellato T, Sivak MV Jr. Endoscopic ultrasonography versus cholangiography for the diagnosis of choledocholithiasis. Gastrointest. Endosc. 1998; 47: 439-48.
52. Buscarini E, Tansini P, Vallisa D, Zambelli A, Buscarini L. EUS for suspected choledocholithiasis: do benefits outweigh costs? A prospective, controlled study. Gastrointest. Endosc. 2003; 57: 510-18.
53. Cotton PB. Endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy. Am. J. Surg. 1993; 165: 474-8.
54. Cotton PB, Baillie J, Pappas TN, Meyers WS. Laparoscopic cholecystectomy and the biliary endoscopist. Gastrointest. Endosc. 1991; 37: 94-7.
55. Palazzo L, O'toole D. EUS in common bile duct stones. Gastrointest. Endosc. 2002; 56: S49-57.
56. Shim CS, Joo JH, Park CW et al. Effectiveness of endoscopic ultrasonography in the diagnosis of choledocholithiasis prior to laparoscopic cholecystectomy. Endoscopy 1995; 27: 428-32.
57. Amouyal P, Amouyal G, Levy P et al. Diagnosis of choledocholithiasis by endoscopic ultrasonography. Gastroenterology 1994; 106: 1062-7.
58. Sugiyama M, Atomi Y. Endoscopic ultrasonography for diagnosing choledocholithiasis: a prospective comparative study with ultrasonography and computed tomography. Gastrointest. Endosc. 1997; 45: 143-6.
59. Polkowski M, Palucki J, Regula J, Tilszer A, Butruk E. Helical computed tomographic cholangiography versus endosonography for suspected bile duct stones: a prospective blinded study in non-jaundiced patients. Gut 1999; 45: 744-9.
60. Soto JA, Alvarez O, Munera F, Velez SM, Valencia J, Ramirez N. Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography, and MR cholangiography. AJR Am. J. Roentgenol. 2000; 175: 1127-34.
61. de Ledinghen V, Lecesne R, Raymond JM et al. Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study. Gastrointest Endosc 1999; 49: 26-31.
62. Ainsworth AP, Rafaelsen SR, Wamberg PA, Durup J, Pless TK, Mortensen MB. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography? Endoscopy 2003; 35: 1029-32.
63. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci. Statements 2002; 19: 1-26.
64. Prat F, Amouyal G, Amouyal P et al. Prospective controlled study of endoscopic ultrasonography and endoscopic retrograde cholangiography in patients with suspected common-bileduct lithiasis. Lancet 1996; 347: 75-9.
65. Jailwala J, Fogel EL, Sherman S et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest. Endosc. 2000; 51: 383-90.
66. Tio TL, Tytgat GN. Endoscopic ultrasonography of bile duct malignancy and the preoperative assessment of local resectability. Scand. J. Gastroenterol. 1986; 123: 151-7.
67. Tio TL, Cheng J, Wijers OB, Sars PR, Tytgat GN. Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging. Gastroenterology 1991; 100: 1351-61.
68. Fritscher-Ravens A, Broering DC, Sriram PV et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest. Endosc. 2000; 52: 534-40.
69. Fritscher-Ravens A, Broering DC, Knoefel WT et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 2004; 99: 45-51.
70. EloubeidiMA, Chen VK, Jhala NC et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 2004; 2: 209-13.
71. Vazquez-Sequeiros E, Baron TH, Clain JE et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest. Endosc. 2002; 56: 372-9.
72. Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest. Endosc. 1996; 44: 656-62.
73. Gress F, Schmitt C, Sherman S, Ciaccia D, Ikenberry S, Lehman G. Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am. J. Gastroenterol. 2001; 96: 409-16.
74. Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest. Endosc. 2001; 54: 316-24.
75. Vitas GJ, Sarr MG. Selected management of pancreatic pseudocysts: operative versus expectant management. Surgery 1992; 111: 123-30.
76. Usatoff V, Brancatisano R, Williamson RC. Operative treatment of pseudocysts in patients with chronic pancreatitis. Br. J. Surg. 2000; 87: 1494-9.
77. Fockens P. EUS in drainage of pancreatic pseudocysts. Gastrointest. Endosc. 2002; 56: S93-7.
78. Caletti G, Brocchi E, Baraldini M, Ferrari A, Gibilaro M, Barbara L. Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest. Endosc. 1990; 36: S21-7.
79. Nakamura H, Endo M, Shimojuu K, Goseki N, Inoue H. Esophageal varices evaluated by endoscopic ultrasonography: observation of collateral circulation during non-shunting operations. Surg. Endosc. 1990; 4: 69-74.
80. Burtin P, Cales P, Oberti F et al. Endoscopic ultrasonographic signs of portal hypertension in cirrhosis. Gastrointest. Endosc. 1996; 44: 257-61.
81. Lee YT, Chan FK, Ching JY et al. Diagnosis of gastroesophageal varices and portal collateral venous abnormalities by endosonography in cirrhotic patients. Endoscopy 2002; 34: 391-8.
82. Sung JJ, Lee YT, Leong RW. EUS in portal hypertension. Gastrointest. Endosc. 2002; 56: S35-43.
83. Faigel DO, Rosen HR, Sasaki A, Flora K, Benner K. EUS in cirrhotic patients with and without prior variceal hemorrhage in comparison with noncirrhotic control subjects. Gastrointest. Endosc. 2000; 52: 455-62.
84. Hino S, Kakutani H, Ikeda K et al. Hemodynamic assessment of the left gastric vein in patients with esophageal varices with color Doppler EUS: factors affecting development of esophageal varices. Gastrointest. Endosc. 2002; 55: 512-7.
85. Chong AK, Colman J, Desmond PV, Chen RY. Correlation of endoscopic ultrasound findings with hepatic venous pressure gradients in portal hypertension - a pilot study. J. Gastroenterol. Hepatol. 2004; 19: A230.
86. Giles G, Thursfield V. Canstat: a digest of facts and figures on cancer. Cancer in Victoria 2002. Cancer Council Victoria 2002; Available from URL: www.cancervic.org.au/cancer1/facts/ pdfs/canstats_42_cancer_vic_2004.pdf [updated 1997; cited 28 December 2006].
87. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003; 123: 115S-28S.
88. Ries LA, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/CSR/1975_2001/2004.
89. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 137S-46S.
90. Wallace MB, Ravenel J, Block MI et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann. Thorac. Surg. 2004; 77: 1763-8.
91. Vansteenkiste JF. PET scan in the staging of non-small cell lung cancer. Lung Cancer 2003; 42: S27-37.
92. Annema JT, Hoekstra OS, Smit EF, Veselic M, Versteegh MI, Rabe KF. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Lung Cancer 2004; 44: 53-60.
93. Caddy G, Conron M, Wright G, Desmond P, Hart D, Chen RY. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur. Respir. J. 2005; 25: 410-15.
94. Gossot D, Toledo L, Fritsch S, Celerier M. Mediastinoscopy vs thoracoscopy for mediastinal biopsy. Results of a prospective nonrandomized study. Chest 1996; 110: 1328-31.
95. Fritscher-Ravens A, Sriram PV, Bobrowski C et al. Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients. Am. J. Gastroenterol. 2000; 95: 2278-84.
96. Hernandez LV, Mishra G, George S, Bhutani MS. A descriptive analysis of EUS-FNA for mediastinal lymphadenopathy: an emphasis on clinical impact and false negative results. Am. J. Gastroenterol. 2004; 99: 249-54.
97. Wiersema MJ, Vazquez-Sequeiros E, Wiersema LM. Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy. Radiology 2001; 219: 252-7.
98. Catalano MF, Nayar R, Gress F et al. EUS-guided fine needle aspiration in mediastinal lymphadenopathy of unknown etiology. Gastrointest. Endosc. 2002; 55: 863-9.
99. Catalano MF, Rosenblatt ML, Chak A, Sivak MV Jr, Scheiman J, Gress F. Endoscopic ultrasound-guided fine needle aspiration in the diagnosis of mediastinal masses of unknown origin. Am. J. Gastroenterol. 2002; 97: 2559-65.
100. Devereaux BM, Leblanc JK, Yousif E et al. Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy. Gastrointest. Endosc. 2002; 56: 397-401.
101. Fritscher-Ravens A, Sriram PV, Topalidis T et al. Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration. Chest 2000; 118: 928-35.
102. Ainsworth AP, Mortensen MB, Durup J, Wamberg PA. Clinical impact of endoscopic ultrasonography at a county hospital. Endoscopy 2002; 34: 447-50.
103. Shah JN, Ahmad NA, Beilstein MC, Ginsberg GG, Kochman ML. Clinical impact of endoscopic ultrasonography on the management of malignancies. Clin. Gastroenterol. Hepatol. 2004; 2: 1069-73.
104. Chong AK, Caddy GR, Desmond PV, Chen RY. Prospective study of the clinical impact of EUS. Gastrointest. Endosc. 2005; 62: 399-405.
105. Palazzo L, Roseau G, Gayet B et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25: 143-50.
106. Kubo H, Chijiiwa Y, Akahoshi K, Hamada S, Matsui N, Nawata H. Pre-operative staging of ampullary tumours by endoscopic ultrasound. Br. J. Radiol. 1999; 72: 443-7.
107. Eloubeidi MA, Jhala D, Chhieng DC et al. Yield of endscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003; 99: 285-92.
108. Bhutani MS, Hawes RH, Baron PL et al. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions. Endoscopy 1997; 9: 854-8.
109. Fritscher-Ravens A, Bohuslavizki KH, Brandt L et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003; 123: 442-51.
110. Annema JT, Veselic M, Versteegh MI, Willems LN, Rabe KF. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer 2001; 42: 311-18.
111. Chang KJ, Soctikno RM, Bastas D, Tu C, Nguyen PT. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Endoscopy 2003; 35: 962-6.
112. Siemsen M, Svendsen LB, Knigge U et al. A prospective randomized comparison of curved array and radial echoendoscopy in patients with esophageal cancer. Gastrointest. Endosc. 2003; 58: 671-6.
113. Weaver SR, Blackshaw GR, Lewis WG et al. Comparison of special interest computed tomography, endosonography and histopathological stage of oesophageal cancer. Clin. Radiol. 2004; 59: 499-504.